CR3 Partners, a national turnaround and performance improvement firm serving the mid-market, today announced that Partner Rob Carringer has been selected to speak at The Annual, the Turnaround...

New subgroup analysis from Eli Lilly and Company's (NYSE: LLY) Phase 3 REVEL trial of CYRAMZA® (ramucirumab) in advanced non-small cell lung cancer (NSCLC) was presented today at the 18th World...

Greenwave Systems, Inc. the global software and managed services leader for the Internet of Things (IoT), today announced its customer deployment of AXON Predict™, its real-time visual edge...

Belgard, the leader in outdoor living essentials for the patio and beyond, is showcasing the future of its products – both in physical display and virtual reality – at Hardscapes North...

3-V Biosciences, Inc., a clinical-stage biopharmaceutical company developing therapeutics for metabolic diseases and oncology, announced today that it will present data on its first-in-class fatty...